Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Discover startups that we recently backed. We've checked the details of each description at time of writing, though these may change. Please enjoy as general information only.
Our fund is open for investment. For more information see here or if you have questions then please get in touch.
Access EIS invested in GroundedGrounded makes protein rich, dairy free milkshakes using only real, natural ingredients "from the ground". It emphasises sustainability and its packaging is 100% recylable.
Access EIS invested in RecommeRecomme is the first 360° white-labelled circularity system for end-of-life product management – from resale to recycling, it helps businesses access the resale and recycle circular economy.
Access EIS invested in Noggin HQNoggin HQ is on a mission to modernise traditional credit assessments, and increase lending to underserved segments. Traditional credit reference agencies rely on data that many people, especially younger people, don't have, so Noggin has designed a credit score specifically for Gen Z and millenials that makes use of data they do have.
Access EIS invested in StacktStackt is a moving and storage tech company that aims to simplify and modernise a very traditional industry. It offers a platform to connect movers and consumers in addition to a storage solution, along with a 360 degree moving service to make moving as simple and effortless as possible.
Access EIS invested in AsanAsan – which means 'worry free' in Persian, Hindi and Urdu – is a social venture with a mission to eradicate period poverty across the world with a reusable, high quality menstrual cup. For each cup purchased, it donates one and provides menstrual health education to women and girls in India.
Access EIS invested in FinexosFinexos combines advanced AI, behavioural analytics and real-time data to reduce risk, costs and default rates for lenders, borrowers and society.
Access EIS invested in FrejaFreja is a husband and wife team that produces 100% natural Norwegian bone broth from pasture-fed cows and free-range chickens that are antibiotic, hormone and GMO free. This is the ultimate cupboard-friendly, responsibly sourced and nutrition-packed fast food.
Access EIS invested in BowimiBowimi's software helps the best challenger F&B brands capture and manage their field sales data faster and more effectively than ever before.
Access EIS invested in UnfabledUnfabled is a consumer health platform transforming women's wellbeing by providing curated & personalised solutions. They emphasise empowering their consumers and sustainable products free of bleach, chemicals or other toxins.
Access EIS invested in Ctrl AltCtrl Alt works to make investing in alternative asset classes simple, secure and accessible. Since launching in 2022, Ctrl Alt has already achieved success tokenising the first property in the UK, bringing to life its mission to enable fractional investing in previously out of reach alternative assets.
Access EIS invested in RoomixRoomix is an all-in-one DIY platform bringing together creator content, brands and design services to turn your inspiration into reality in your home.
Access EIS invested in Pencil BiosciencesPencil Biosciences is developing an innovative gene editing technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases.
Access EIS invested in IsosConnectIsosconnect have created a platform that optimises fundamental clinical processes, caters for safe online consultations and offers the opportunity for peer-to-peer work between modalities and specialties to create a digital home for independent health and wellbeing practitioners.
Access EIS invested in AppFactorAppFactor is designed to eliminate the time, risk and cost constraints of manually modernising business applications, delivering a scalable, repeatable factory model purpose-built for cloud native modernisation. It allows users to accelerate the journey to cloud-native architecture and modernised DevOps.
Access EIS invested in ThymiaThymia's ethical AI models analyse voice, movement and behaviour to provide clinical grade insights into mental health and wellbeing. At the pre-clinical level it works with providers of mental wellbeing to measure indicators of burnout and other pre-clinical indicators of mental health. At the clinical level it is developing a tool to support clinicians in triaging, diagnosing and more effectively treating mental illness.
Access EIS invested in AnansiAnansi has developed a better way for merchants to insure goods in transit that brings a frequently frustrating system up to 21st century standards, with digitised processes and automated, hassle-free claims forming the basis for a range of insurance products.
Access EIS invested in MettleMettle (formerly Headshed) develops a wellness app for men, providing guidance for meditation, breathwork, and "mind-hacking".
Access EIS invested in RenewablRenewabl is a platform that allows companies to quickly and efficiently meet their decarbonisation targets by matching clean renewable energy certificates directly from real wind and solar farms on a 24/7 basis using blockchain.
Access EIS invested in EdozoEdozo develops software that allows people in the commercial property industry to store, manage, track and search property deals.
Access EIS invested in ConcrConcr is a mission-driven techbio company that answers essential questions in oncology through solving data. By adopting astrophysics methods used to study the universe, Concr unlocked the ability to effectively integrate diverse and incomplete datasets to help scientists identify and develop molecular features of patient response ('biomarkers') for their drugs with 300x less pre-clinical and 7x less clinical data. Using Concr's cloud-based platform, FarrSight™, researchers can make advanced predictions about biomarkers, model patient response by leveraging Concr's unique technology, and perform standard bioinformatics analyses directly.